Fujitsu 2004 Annual Report Download - page 13

Download and view the complete annual report

Please find page 13 of the 2004 Fujitsu annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 60

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60

11
in business and other settings, we developed the
world’s first contactless palm vein pattern biometric
authentication technology. This technology is able to
verify a person’s identity by reading – without physical
contact – the pattern of blood veins in the individual’s
palm and comparing it to a pre-registered pattern.
Since there is no contact with sensor equipment, this
method is advantageous in terms of public hygiene,
and because it is based on internal biometric
information, it offers superior protection against
identity theft.
In the world’s first deployments of this technology,
Suruga Bank will use it at its teller windows, and
Tokyo Mitsubishi Bank will use at its teller windows as
well as in its ATMs. Tokyo Mitsubishi Bank is also
planning to utilize the biometric technology together
with its multi-function IC cards starting this fall.
We aim to deploy the technology in a broad range of
applications, particularly in public places where
concerns for hygiene are particularly important.
New ATMs incorporate pioneering palm vein pattern authentication technology.
World’s fastest quantum chemical computational techniques and software are helping to speed drug development.
School of Medicine, we succeeded in proving the
validity of our efficient computer-based calculation of
the mechanisms for specific AIDS drug treatments and
their associated proteins currently being used in
clinical practice. Instead of employing animal
experiments and other traditional methods, the
experiment was carried out with just one PC,
successfully performing a simulation analysis in an
effective time of about 3 hours and 40 minutes.
In addition to reducing the time and expense
required for drug development, it is expected that this
technology will be used as a preventative tool for
predicting issues such as potential adverse side effects,
and will help open the way toward exciting new
possibilities in genomic drug design.
Tokyo Mitsubishi Bank and Suruga Bank
First Deployments of Palm Vein Pattern
Authentication Technology for Secure Banking
Responding to growing needs for identity verification